April 1, 2021 – Spectrum Health (Grand Rapids, MI) and Medtronic plc (Dublin, Ireland) have entered into an agreement to explore the creation of value-based healthcare programs to support the evidence-based adoption and appropriate use of medical technologies and therapies at Spectrum Health.
Spectrum Health System is a not-for-profit, integrated health system offering a full continuum of care and wellness services through 14 hospitals, 150 ambulatory sites and telehealth offerings.
Through the collaboration Spectrum Health will work to develop and deploy value-based healthcare programs designed to address health conditions impacting patients and communities in West Michigan.
Together, the organizations will use data and near real-time analytics to design programs intended to help standardize care, reduce clinical variation, and deliver greater personalization of care by applying the right medical technologies and therapies to patients who may benefit most.
The first program will be designed around Cardiac Resynchronization Therapy for patients with heart failure and electrical dyssynchrony. Spectrum Health will work with Medtronic on a program designed to automate the identification of readmission events in patients who receive a Medtronic Cardiac Resynchronization Therapy device with the AdaptivCRT algorithm under an existing financial accountability program.
The AdaptivCRT algorithm adjusts therapy according to minute-by-minute evaluations of a patient’s heart rhythm and has been shown to reduce the likelihood of 30-day heart failure hospital readmissions, reduce the risk of atrial fibrillation, and improve patient survival, the company says.
Spectrum Health says it will also carefully evaluate how medical device technology is used within a care pathway to understand the value created. Programs will have clearly defined metrics to help achieve the goal of improving patient outcomes while reducing the cost of care.